Source BioScience News
In addition to the news article below, please refer to the regulatory news announcements
available from the investor relations page.
Notice of Results
8 March 2010
Source BioScience plc expects to announce its preliminary results for the year ended 31 December 2009 on 24 March 2010. There will be a presentation for analysts at 10.00am on 24 March at the offices of Bishopsgate Communications, 5-11 Worship Street, London, EC2A 2BH. Analysts wishing to attend should contact Gemma O'Hara at Bishopsgate Communications (0207 562 3350) before 12.00 on 22 March. The results presentation will be made available on the Company's website, www.sourcebioscience.com, after commencement of the meeting.
Source BioScience opens DNA sequencing facility in Dublin
23 February 2010
The Company is pleased to announce the opening of its new DNA sequencing laboratory based in Dublin, Ireland.
Source BioScience Healthcare adds Gastric HER2 test to portfolio
15 February 2010
Source BioScience Healthcare, a leading provider of histopathology, diagnostic tests and cytology services to the NHS and private hospitals, is pleased to announce the addition of a new Gastric HER2 test to its portfolio of tests. This follows the recent approval by the European Medicines Agency of the use of Herceptin in the treatment of metastatic gastric cancer. Source BioScience is the only laboratory in the UK offering this test. For more information please go to
GASTRIC HER2 test or contact our Business Development Team on 0115 79739056.
Change of Advisor and Joint Stockbroker
15 February 2010
The Board of Source BioScience plc is pleased to announce the appointment with immediate effect of Singer Capital Markets Limited as the Company's Financial Advisor and Joint Stockbroker.
Source BioScience attendance at the Molecular Medicine Triconference, San Francisco, 1- 5 February
28 January 2010
Dr Jackie Rodgers, Head of Business Development, Pharma Biotech Worldwide for Source BioScience, the Nottingham, UK based healthcare and biotechnology company, will be attending the Molecular Medicine Triconference in San Francisco from the 1st - 5th February. The Company is presenting a poster entitled "A comparison of methods for retrieval of DNA and RNA from FFPE tissues". Dr Rodgers would be pleased to meet with companies wishing to discuss how Source BioScience could be of assistance in this area of expertise. Please contact her via email - jackie.rodgers@sourcebioscience.com.
Source BioScience trebles next generation DNA sequencing capacity
26 January 2010
The Company is pleased to announce the purchase of a further two Illumina Genome Analyzer IIx™ platforms to significantly enhance its DNA sequencing service.